retatrutide triple agonist phase 2 obesity trial glp-1 gip glucagon nejm 2023 Medscape triple-hormone-receptor agonist retatrutide for obesity
Pay in 4 interest-free payments of $7.47 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25

























